MedTrace Logo

Optimal Amount of Zinc to Include in a Lipid-based Nutrient Supplement (LNS)

NCT00944281 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3220

Last updated 2018-07-13

No results posted yet for this study

Summary

To assess zinc-related biochemical and functional responses among young Burkinabe children with a presumed high risk of zinc deficiency who receive micronutrient products containing different amounts of zinc, provided with or between meals.

Conditions

  • Malnutrition

Interventions

DIETARY_SUPPLEMENT

LNS-Zn5

Daily consumption of 20 g LNS containing 5 mg of zinc and daily placebo supplement

DIETARY_SUPPLEMENT

LNS-Zn10

Daily consumption of 20 g LNS containing 10 mg of zinc and daily placebo supplement

DIETARY_SUPPLEMENT

LNS-Zn0

20 g of LNS containing 0 mg of zinc and a daily placebo supplement

DIETARY_SUPPLEMENT

Suppl-Zn5

Daily 5 mg zinc supplement ant consumption of 20 g LNS containing 0 mg of zinc

Sponsors & Collaborators

  • Université Polytechnique de Bobo-Dioulasso

    collaborator OTHER

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Kathryn Dewey, PhD · University of California, Davis

  • Kenneth H Brown, MD · University of California, Davis

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
9 Months
Max Age
9 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Burkina Faso

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00944281 on ClinicalTrials.gov